Could a Bloodstream Test for Cancer Of The Breast Be realized

 

University of Leicester developes blood test to detect breast cancer

Video taken from the channel: University of Leicester News Centre


 

Possible blood test to detect breast cancer

Video taken from the channel: FOX 5 Atlanta


 

Mutation-tracking’ blood test could predict breast cancer relapse

Video taken from the channel: The Institute of Cancer Research, London


 

Simple blood test could identify early signs of breast cancer | Nine News Australia

Video taken from the channel: 9 News Australia


 

BREAST CANCER: Blood tests available that could catch the disease early

Video taken from the channel: NewsNOW from FOX


 

Simple blood test could be used to detect breast cancer

Video taken from the channel: The University of Western Australia


 

Blood test could help detect breast cancer

Video taken from the channel: CBS News


MONDAY, Nov. 4, 2019 (HealthDay News) There’s early promise in the quest for a blood test that might spot breast cancer up to five years before clinical signs of. MONDAY, Nov. 4, 2019 (HealthDay News) There’s early promise in the quest for a blood test that might spot breast cancer up to five years before clinical signs of.

Could a Blood Test for Breast Cancer Become a Reality? MONDAY, Nov. 4, 2019 There’s early promise in the quest for a blood test that might spot breast cancer up to five years before clinical signs of the disease appear, researchers say. The test identifies specific immune system “autoantibodies,” British researchers explained. Breast cancer may soon be diagnosed by means of a blood test. There’s early promise in the quest for a blood test that might spot breast cancer up to five years before clinical signs.

Could a Blood Test for Breast Cancer Become a Reality? En Español MONDAY, Nov. 4, 2019 (HealthDay News) There’s early promise in the quest for a blood test that might spot breast cancer up to five years before clinical signs of the disease appear, researchers say. Could a Blood Test for Breast Cancer Become a Reality? There’s early promise in the quest for a blood test that might spot breast cancer up to five years before clinical signs of the disease appear, researchers say.

The test identifies specific immune system “autoantibodies,” British researchers explained. MONDAY, Nov. 4, 2019 (HealthDay News) There’s early promise in the quest for a blood test that might spot breast cancer up to five years before clinical signs of the disease appear, researchers say. Could a Blood Test for Breast Cancer Become a Reality?

MONDAY, Nov. 4, 2019 (HealthDay News) There’s early promise in the quest for a blood test that might spot breast cancer up to five years before clinical signs of the disease appear, researchers say. Quick Guide.

Close. Menu. When a breast cancer blood marker test comes back negative, it doesn’t necessarily mean you’re free and clear of breast cancer.

And a positive result doesn’t always mean that the cancer is growing. These tests may help with diagnosis, but using cancer marker tests to find metastatic breast cancer hasn’t helped improve survival yet.

List of related literature:

Molecular tests exist to help determine treatment options following breast cancer diagnoses, but prospects for blood tests to detect the disease are scant.

“Encyclopedia of Cancer” by Manfred Schwab
from Encyclopedia of Cancer
by Manfred Schwab
Springer Berlin Heidelberg, 2011

Current thinking postulates that these studies may, in fact, constitute detection studies rather than incidence studies, because it is known that breast cancer cells can be present in the body for 8 to 10 years before the cancer can be detected by any currently available means.

“Porth Pathophysiology: Concepts of Altered Health States” by Ruth A. Hannon, Charlotte Pooler, Carol Mattson Porth
from Porth Pathophysiology: Concepts of Altered Health States
by Ruth A. Hannon, Charlotte Pooler, Carol Mattson Porth
Lippincott Williams & Wilkins, 2009

This can be found with a diverse variety of cancers, including carcinomas of the breast, liver, and gastrointestinal tract; melanoma; and multiple myeloma,” and can serve as a source of confusion when performing routine pregnancy testing prior to administration of chemotherapy or radiation treatment.

“Medical Care of Cancer Patients” by Sai-Ching Jim Yeung, Carmen P. Escalante, Robert F. Gagel
from Medical Care of Cancer Patients
by Sai-Ching Jim Yeung, Carmen P. Escalante, Robert F. Gagel
People’s Medical Publishing House, 2009

In many cases, these changes may include proteins that cells secrete into the bloodstream, which is where the idea of a blood test for diseases including cancer comes in.

“The End of Illness” by David B. Agus
from The End of Illness
by David B. Agus
Free Press, 2012

They do not identify the risk of developing cancer; rather, prediction will depend on the results of the test aiming at determining inherited predisposition for breast cancer.

“Holland-Frei Cancer Medicine Cloth” by Robert C. Bast, Jr., Carlo M. Croce, William N. Hait, Waun Ki Hong, Donald W. Kufe, Martine Piccart-Gebart, Raphael E. Pollock, Ralph R. Weichselbaum, Hongyang Wang, James F. Holland
from Holland-Frei Cancer Medicine Cloth
by Robert C. Bast, Jr., Carlo M. Croce, et. al.
Wiley, 2017

Given that the prevalence of breast cancer in young woman is low, such testing would yield numerous false positives, necessitating unnecessary referrals and expensive workups by specialists, not to mention a lot of unneeded anxiety!

“USMLE Step 1 Secrets E-Book” by Thomas A. Brown, Sonali J Bracken
from USMLE Step 1 Secrets E-Book
by Thomas A. Brown, Sonali J Bracken
Elsevier Health Sciences, 2012

Some such tests are already available, such as a test for estrogen receptors in a breast tumor sample to see whether the drug Herceptin will be effective.

“Encyclopedia of Special Education: A Reference for the Education of Children, Adolescents, and Adults with Disabilities and Other Exceptional Individuals” by Cecil R. Reynolds, Elaine Fletcher-Janzen
from Encyclopedia of Special Education: A Reference for the Education of Children, Adolescents, and Adults with Disabilities and Other Exceptional Individuals
by Cecil R. Reynolds, Elaine Fletcher-Janzen
Wiley, 2007

Prior studies have shown that analysis of circulating tumour DNA (ctDNA) can detect micro-scopic minimal residual disease (MRD) serving as biomarker to anticipate future cancer recurrence, although sensitivity of current assays is limited.

“AACR 2018 Proceedings: Abstracts 3028-5930” by American Association for Cancer Research
from AACR 2018 Proceedings: Abstracts 3028-5930
by American Association for Cancer Research
CTI Meeting Technology, 2018

(Since not all breast cancers are estrogen-dependent, a sample of the tumor can be readily tested to determine whether or not it contains estrogen receptors before treatment is begun.)

“Molecules of Emotion: Why You Feel the Way You Feel” by Candace B. Pert, Deepak Chopra, Candace Pert (Biochemikerin, USA)
from Molecules of Emotion: Why You Feel the Way You Feel
by Candace B. Pert, Deepak Chopra, Candace Pert (Biochemikerin, USA)
Scribner, 1997

Testing for the presence of estrogen and progesterone receptors helps to identify breast cancer if receptor levels are high; however, these receptors are also found in a number of other malignancies, including ovarian and endometrial cancers, reducing specificity if levels are not high.

“Primary Care Medicine: Office Evaluation and Management of the Adult Patient” by Allan H. Goroll, Albert G. Mulley
from Primary Care Medicine: Office Evaluation and Management of the Adult Patient
by Allan H. Goroll, Albert G. Mulley
Wolters Kluwer Health/Lippincott Williams & Wilkins, 2009

Oktay Kutluk

Kutluk Oktay, MD, FACOG is one of the world's foremost experts in fertility preservation as well as ovarian stimulation and in vitro fertilization for infertility treatments. He developed and performed the world's first ovarian transplantation procedures as well as pioneered new ovarian stimulation protocols for embryo and oocyte freezing for breast and endometrial cancer patients.

Mail: [email protected]
Telephone: +1 (877) 492-3666

Biography: https://medicine.yale.edu/profile/kutluk_oktay/
Bibliography: oktay_bibliography

View all posts

2 comments

Your email address will not be published. Required fields are marked *

  • Quit using deodorant with metal. Duh your body absorbs the metal and becomes a tumor in your breast. Just saying makes since to me

  • Then why can’t we just skip the mammogram and just do the blood test. I also have dense breast tissue and, yes, mammos are useless and extremely painful.
    This video doesn’t explain how to get this test….